OPEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Opendoor Technologies Inc (OPEN) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company shows some recovery in acquisitions and has a positive SwingMax signal, the financials remain weak, with significant losses and declining revenue. Additionally, hedge funds are selling, and Congress trading data shows caution with no purchase transactions. The stock's pre-market decline, combined with a lack of strong AI Stock Picker signals and mixed analyst sentiment, suggests holding off on buying until clearer signs of sustained growth and profitability emerge.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 57.239, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in price direction. Key support and resistance levels are Pivot: 5.094, R1: 5.467, S1: 4.722, R2: 5.697, S2: 4.492. Pre-market price is $5.10, down -1.54%, nearing the pivot level.
SwingMax signal from 2026-02-24 with a 3.34% price increase since then.
46% quarter-over-quarter increase in acquisitions, showing potential recovery in market demand.
Positive commentary on margins for newer cohorts.
Hedge funds are selling, with a 192.84% increase in selling activity last quarter.
Congress members made 4 sale transactions with no purchases in the last 90 days.
Financials show a -32.10% YoY revenue decline and significant losses.
Analysts remain cautious with Neutral and Hold ratings, and price targets are modest.
Management forecasts a 10% revenue decline for Q1 2026.
In Q4 2025, revenue dropped to $736 million, down -32.10% YoY. Net income increased to -$1.096 billion, up 869.91% YoY, but remains deeply negative. EPS improved to -1.26, up 687.50% YoY. Gross margin dropped slightly to 7.74%, down -1.28% YoY. The company remains unprofitable, with management targeting breakeven adjusted net income by year-end.
Analysts are cautious with Neutral and Hold ratings. UBS raised the price target to $5 from $1.60, and Deutsche Bank raised it to $4 from $0.90. BTIG reiterated a Neutral rating, noting it is too early to validate the new strategy's success. Analysts tentatively model higher margins but still expect losses.
